Abiopharma

Clinical trial NCT04895709 updates: 1. completion date: 2028-07-07 → 2031-08-31 2. primary completion date: 2028-07-07 → 2031-08-31 3. enrollment: 949 → 1109 participants 4. allocation: NON_RANDOMIZED → RANDOMIZED

Clinical trial NCT06165016 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-01 → 2026-12-31 3. primary completion date: 2027-01-30 → 2026-09-30 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03774758 updates: 1. completion date: 2025-12-31 → 2030-12-31 2. primary completion date: 2025-12-31 → 2030-12-31

Clinical trial NCT02687906 updates: 1. completion date: 2025-12-01 → 2026-12-01 2. primary completion date: 2025-12-01 → 2026-12-01

Clinical trial NCT06692933 updates: 1. completion date: 2025-12-31 → 2027-12-31 2. primary completion date: 2025-08-31 → 2027-08-31

Clinical trial NCT05424003 updates: 1. completion date: 2026-02-01 → 2026-08-01 2. primary completion date: 2026-02-01 → 2026-08-01

Clinical trial NCT07021989 updates: 1. start date: 2026-05-01 → 2026-07-01 2. completion date: 2033-10-31 → 2033-12-31 3. primary completion date: 2029-03-31 → 2029-05-31

Clinical trial NCT07559019 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-05-21

Clinical trial NCT07287670: start date: 2026-05-01 → 2026-04-16.

Clinical trial NCT03632941 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-12-01 → 2024-06-26 3. primary completion date: 2023-10-03 → 2023-09-03